Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Mutagenesis ; 6(5): 391-4, 1991 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-1795644

RESUMO

Starting with the results of the mutagenicity of 100 chemicals, we use CASE, a structure activity relational system, to select additional chemicals for inclusion into a data base. We demonstrate that a data base consisting of approximately 180 carefully selected chemicals is as predictive as the analysis based upon 820 'unselected' chemicals.


Assuntos
Bases de Dados Factuais , Testes de Mutagenicidade/estatística & dados numéricos , Relação Estrutura-Atividade , Toxicologia/métodos , Sistemas de Informação , Mutagênicos/toxicidade , Valor Preditivo dos Testes , Salmonella/efeitos dos fármacos , Software
2.
Prog Clin Biol Res ; 340D: 295-304, 1990.
Artigo em Inglês | MEDLINE | ID: mdl-2115175

RESUMO

Choosing a cost-effective strategy for classifying chemicals as human carcinogens and non-carcinogens depends upon the costs of false positives (carcinogens erroneously treated as non-carcinogenic) and false negatives (non-carcinogens erroneously treated as carcinogenic); upon the accuracy (sensitivity and specificity) of the classification strategy; and upon the underlying proportion of carcinogens in the population of chemicals to be classified. If these values are known, value-of-information analyses can indicate the most cost-effective among three strategies: classify as carcinogenic without testing, classify as non-carcinogenic without testing, or choose the most cost-effective test and classify on the basis of the test result. When some or all of the values are uncertain, the analysis becomes more complex, but still helps to guide decisions among the three classification strategies.


Assuntos
Testes de Carcinogenicidade/economia , Carcinógenos/classificação , Animais , Análise Custo-Benefício , Interpretação Estatística de Dados , Humanos , Valor Preditivo dos Testes , Probabilidade
4.
Toxicol Ind Health ; 4(2): 137-49, 1988 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-3140422

RESUMO

Assessment of the risk to humans posed by chemical substances currently relies primarily on experimental exposure of animals in lifetime feeding studies. Short-term tests for genotoxicity are much less costly and use fewer or no animals, but have not replaced the long-term animal bioassay because their results do not coincide completely. We have developed methodologies for interpretation of short-term tests which improve the usefulness of their results, and may allow them to replace the long-term animal bioassay in some circumstances.


Assuntos
Alternativas aos Testes com Animais , Testes de Carcinogenicidade/métodos , Interpretação Estatística de Dados , Animais , Análise Custo-Benefício , Valor Preditivo dos Testes , Especificidade da Espécie , Fatores de Tempo
5.
Mutat Res ; 197(1): 1-13, 1988 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-3122033

RESUMO

The cost-effectiveness of using short-term genotoxicity tests to screen unknown chemicals for carcinogenicity depends upon the inherent reliability of the tests (sensitivity, or fraction of carcinogens giving positive results, and specificity, or fraction of non-carcinogens giving negative results) and also upon the proportion of carcinogens in the population of chemicals to be screened. Individual tests may be combined into batteries to improve reliability; however, this requires decision rules to declare the overall result positive or negative. A framework for developing such rules based upon minimizing costs of false-positives and false-negatives was presented in a seminal paper by Lave and Omenn (1986, Nature (London), 324, 29-34). We have extended their work, which is based on logit analysis, to consider, using Bayes' theorem, the influence of the proportion of carcinogens upon the decision rules for declaring a battery result positive or negative. If the proportion of carcinogens is high (20% or greater), then the most effective tests are those with high sensitivity, and if the proportion of carcinogens is low, then the most effective tests are those with high specificity.


Assuntos
Carcinógenos/farmacologia , Testes de Mutagenicidade , Animais , Linhagem Celular , Análise Custo-Benefício , Estudos de Avaliação como Assunto , Reações Falso-Negativas , Reações Falso-Positivas , Estados Unidos
6.
Food Chem Toxicol ; 25(3): 247-51, 1987 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-3106176

RESUMO

Published data on the mutagenicity and genotoxicity of theobromine and caffeine were analysed by the Carcinogen Prediction and Battery Section (CPBS) method. In spite of some positive responses, these analyses did not predict for theobromine a potential for causing cancer by virtue of a genotoxic mechanism. Caffeine, on the other hand, clearly has potential for genotoxic carcinogenicity. The predictive performance of cost-effective batteries consisting of selected combinations of four assays was also evaluated. The predictions were similar to those derived when all the available test results were considered.


Assuntos
Cafeína/toxicidade , Testes de Mutagenicidade/métodos , Mutagênicos , Teobromina/toxicidade , Teorema de Bayes , Análise Custo-Benefício , Valor Preditivo dos Testes
7.
Mutat Res ; 150(1-2): 1-11, 1985.
Artigo em Inglês | MEDLINE | ID: mdl-3889611

RESUMO

Two procedures for predicting the carcinogenicity of chemicals are described. One of these (CASE) is a self-learning artificial intelligence system that automatically recognizes activating and/or deactivating structural subunits of candidate chemicals and uses this to determine the probability that the test chemical is or is not a carcinogen. If the chemical is predicted to be carcinogen, CASE also projects its probable potency. The second procedure (CPBS) uses Bayesian decision theory to predict the potential carcinogenicity of chemicals based upon the results of batteries of short-term assays. CPBS is useful even if the test results are mixed (i.e. both positive and negative responses are obtained in different genotoxic assays). CPBS can also be used to identify highly predictive as well as cost-effective batteries of assays. For illustrative purposes the ability of CASE and CPBS to predict the carcinogenicity of a carcinogenic and a non-carcinogenic polycyclic aromatic hydrocarbon is shown. The potential for using the two methods in tandem to increase reliability and decrease cost is presented.


Assuntos
Carcinógenos , Testes de Mutagenicidade , Animais , Computadores , Camundongos , Mutagênicos , Compostos Policíclicos/toxicidade , Probabilidade , Salmonella typhimurium/efeitos dos fármacos , Pele/efeitos dos fármacos , Relação Estrutura-Atividade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA